Tag: protein therapeutics

Nabla Bio and Takeda have announced a significant expansion of their partnership, entering a multi-year collaboration potentially exceeding $1 billion to develop AI-driven protein therapeutics. This deal leverages Nabla Bio's proprietary Joint Atomic Model (JAM) platform to accelerate Takeda's early-stage drug discovery programs, focusing on novel antibody design and other custom biologics.